Yingwei Peng

Affiliations: 
Mathematics and Statistics Queen's University, Canada, Kingston, Ontario, Canada 
Area:
Statistics
Google:
"Yingwei Peng"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liang H, Wang X, Peng Y, et al. (2023) Improving marginal hazard ratio estimation using quadratic inference functions. Lifetime Data Analysis
Yang L, Song H, Peng Y, et al. (2020) Joint analysis of longitudinal measurements and survival times with a cure fraction based on partly linear mixed and semiparametric cure models. Pharmaceutical Statistics
Ge X, Peng Y, Tu D. (2020) A threshold linear mixed model for identification of treatment-sensitive subsets in a clinical trial based on longitudinal outcomes and a continuous covariate. Statistical Methods in Medical Research. 962280220912772
Jamaspishvili T, Patel PG, Niu Y, et al. (2020) Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN). Journal of the National Cancer Institute
Niu Y, Wang X, Cao H, et al. (2020) Variable selection via penalized generalized estimating equations for a marginal survival model. Statistical Methods in Medical Research. 962280220901728
Saleh R, Bedard PL, Nguyen P, et al. (2020) An evaluation of administrative data linkage for measurement of real-world outcomes of large clinical panel sequencing for advanced solid tumors. Journal of Clinical Oncology. 38: e19303-e19303
Raphael MJ, Siemens R, Peng Y, et al. (2020) Volume of systemic cancer therapy delivery and outcomes of patients with solid tumors: A systematic review and methodologic evaluation of the literature Journal of Cancer Policy. 23: 100215
Karim S, Mackillop WJ, Brennan K, et al. (2019) Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer. Cancer Medicine
Karim S, Booth CM, Brennan K, et al. (2019) Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer. Cancer Medicine
Merchant SJ, Brogly SB, Booth CM, et al. (2019) Management of Cancer-Associated Intestinal Obstruction in the Final Year of Life. Journal of Palliative Care. 825859719861935
See more...